Communiqués

04/08 Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S. AQ
06/07 Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida AQ
20/05 Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa AQ
13/05 Grey Matters Health : Investor Presentation PU
05/05 Grey Matters Health : Investor Presentation PU
01/05 Grey Matters Health : Financial Statements Q2 2026 PU
01/05 Grey Matters Health : MD&A Q2 2026 PU
22/04 Algernon Health : Grey Matters Health Investor Presentation PU
15/04 Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation AQ
01/04 Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation AQ
26/03 Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS as the New Brand Name for its U.S. Brain PET scanning Centers AQ
25/03 Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers AQ
23/03 Algernon Health : to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building PU
23/03 Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building  AQ
29/11 Algernon Health : Closes Second Tranche of Private Placement Financing PU
17/11 Algernon Health : and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement PU
06/11 Algernon Health Announces Private Placement AQ
16/10/25 CSE Bulletin: Name Change - Algernon Pharmaceuticals Inc. (AGN) NE
15/10/25 Algernon Pharmaceuticals Completes Name Change to Algernon Health AQ
25/09/25 Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection AQ
19/09/25 Algernon Announces Preferred Share Class Approved at Annual and Special Meeting AQ
04/09/25 Algernon Pharmaceuticals Announces Name Change to Algernon Health AQ
24/07/25 Algernon Announces Closing of the Private Placement Financing AQ
30/06/25 Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000 AQ
26/06/25 Algernon Pharmaceuticals : Corporate Fact Sheet June 2025 PU
Aucun résultat pour cette recherche